✦ LIBER ✦
PCV71 COST-EFFECTIVENESS OF EZETIMIBE/SIMVASTATIN VERSUS SIMVASTATIN: WILL THE INCREASED RISK OF CANCER MAKE EZETIMIBE/SIMVASTATIN AN INAPPROPRIATE TREATMENT CHOICE?
✍ Scribed by CC Wang; AK Biddle; JF Farley
- Book ID
- 118611431
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 89 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.